In summary, NCTD effectively inhibits the malignant proliferation of colon cancer cells by regulating the TRAF5/NF-κB signaling pathway and inducing programmed apoptosis, offering a novel treatment strategy. The gene discussed is TRAF5; the disease is malignant colon neoplasm.